Crizotinib 53869-2231
Product NDC
53869-2231- Manufacturer
- Pfizer Manufacturing Deutschland Gmbh (betriebssttte Freiburg)
- Dosage Form
- Capsule
- Product Type
- Drug For Further Processing
- Marketing Start
- September 30, 2011
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Crizotinib | 200 mg/1 |
Packaging Options(1)
60 CAPSULE in 1 BOTTLE (53869-2231-1)